Emit Imaging

04/25/2023

Join us for a live webinar hosted by Endpoints News on April 27 at 11 am ET. Industry experts from Emit Imaging, Invicro & REGENXBIO Inc. introduce cryo-fluorescence tomography (CFT), a novel 3D imaging approach, and its applications in gene therapy expression and vector biodistribution
Register Here: https://koi-3QNTQ95M7Q.marketingautomation.services/net/m?md=qXS8p4weUS3tTcDauPYUBKPFeuAOTWtm

04/20/2023

We are delighted to announce our collaboration with MIT Koch Institute for Integrative Cancer Research.
Read the article here: https://emitimaging.com/about-us/mit-press-release/

04/18/2023

We are at AACR this week! Visit us at Booth 259 to see the latest about Cryo-Fluorescence Tomography!

04/14/2023

We are headed to Orlando, FL for AACR 2023! Excited to see those attending, make sure you stop by Booth 259.

04/13/2023

Join us for a live webinar hosted by Endpoints News on April 27 at 11am ET. Industry experts from Emit Imaging, Invicro & REGENXBIO Inc. introduce cryo-fluorescence tomography (CFT), a novel 3D imaging approach and its applications in gene therapy expression and vector biodistribution
Register Here: https://koi-3QNTQ95M7Q.marketingautomation.services/net/m?md=qXS8p4weUS2nHnvztr4xjQeSYInoQaVA

10/06/2022

Excited to share with you our latest EMIT Imaging. Hope you like it - Meet EMIT IMAGING and Xerra.

Meet Xerra, an important 3D tissue imaging technology developed by EMIT IMAGING. This preclinical imaging platform, is arguably the most disruptive imaging ...

08/31/2022

Preclinical tumor metastasis models are common, butare difficult to visualize and subsequently quantify accurately. MRI lacks sensitivity and specificity at early stage metastasis, while PET, SPECT and optical techniques lack resolution. Cryo-Fluorescence Tomography (CFT) is a new ex-vivo imaging modality combining cryo slicing with serial fluorescence and anatomical white light imaging. This technique provides a whole-body molecular 3D data set which shows the extent of metastasis.

The image below shows that bioluminescence imaging has excellent specificity but lacks sufficient resolution to quantify tumor metastases, especially at depth. Cryo-Fluorescence Tomography can be used as an ex-vivo imaging modality to complement bioluminescence imaging and identify small tumors with a resolution down to 20um.

Learn more: https://lnkd.in/g-65qMEa

08/31/2022

Use Cryo-Fluorescence Tomography (CFT) to Quantify and Trace Drug Movement in One Step:

In this experiment, a fluorescent tracer, Cy7 conjugated therapeutic, was injected into a murine model. Their brains were collected at different time points. Using CFT, the brains were sliced, imaged and processed. 3D reconstructions showed the movement of the tracer across the brain from 1 hour to 12 hours (top panel). Tracer concentration was quantified across time and in different regions of the brains. Using Xerra, the CFT platform, a drug’s pharmacokinetics can be visualized, quantified and traced in real-time.

Learn more: https://emitimaging.com/applications/neuroscience/